Seed, Pre-Seed
$1.5M – $10.0M
$68M
16+ companies
5 partners
Investment Thesis
Astellas Venture Management invests in early-stage therapeutic innovation, focusing on biopharma and AI-based drug design.
Meet the Team
Industry Focus
Invests In
Portfolio Companies (16)
Other
Atomwise
Vector BioPharma
DeepSeq.AI
Serna Bio
Solu Therapeutics
Develops therapeutics targeting soluble targets in immunology and inflammation.
PhoreMost
UK-based developer of small molecule neoantigen immuno-oncology therapies.
Somite Therapeutics
Builds cellular therapies for muscle diseases using stem cell tech.
Turn Biotechnologies
Develops mRNA-based therapies for cellular rejuvenation in age-related diseases.
CoMentis
Focuses on neurodegenerative disease therapies targeting protein misfolding.
Avilar Therapeutics
Engineers protein degradation platforms for autoimmune and inflammatory diseases.
- •Raising at Seed, Pre-Seed? You're squarely in their sweet spot.
- •Lead with your fit in Other, Healthcare, AI / ML — the sectors they actively back.
- •Size your ask to their typical $1.5M – $10.0M check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as Shinichi Miyake, Ph.D., MBA, Investment Lead.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Astellas Venture Management is a match for your startup
Upload your pitch deck to see how well you match with Astellas Venture Management and 10,000+ other investors.
Is this your profile? Request a correction or removal